HEADER Transferase/Transferase Inhibitor 31-DEC-69 5W5O TITLE Identification of potent and selective RIPK2 inhibitors for the TITLE 2 treatment of inflammatory diseases. COMPND MOL_ID: 1; COMPND 2 MOLECULE: Receptor-interacting serine/threonine-protein kinase 2; COMPND 3 CHAIN: A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P; COMPND 4 EC: 2.7.11.1,2.7.10.2; COMPND 5 FRAGMENT: UNP residues ; COMPND 6 ENGINEERED: YES; EXPDTA X-RAY DIFFRACTION REMARK 2 RESOLUTION. 2.89 ANGSTORMS REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU G 48 REMARK 465 HIS G 49 REMARK 465 ILE G 50 REMARK 465 HIS G 51 REMARK 465 THR G 52 REMARK 465 PRO G 53 REMARK 465 LEU G 54 REMARK 465 LEU G 55 REMARK 465 ASP G 56 REMARK 465 MET G 172 REMARK 465 SER G 173 REMARK 465 LEU G 174 REMARK 465 SER G 175 REMARK 465 GLN G 176 REMARK 465 SER G 177 REMARK 465 ARG G 178 REMARK 465 SER G 179 REMARK 465 SER G 180 REMARK 465 LYS G 181 REMARK 465 SER G 182 REMARK 465 ALA G 183 REMARK 465 PRO G 184 REMARK 465 GLU G 185 REMARK 465 GLY G 186 REMARK 465 GLY G 200 REMARK 465 GLN G 201 REMARK 465 LYS G 202 REMARK 465 SER G 203 REMARK 465 ARG G 204 REMARK 465 ALA G 205 REMARK 465 SER G 206 DBREF 5W5O G 2 311 UNP O43353 RIPK2_HUMAN 2 311 SEQRES 1 G 306 ALA ILE CYS SER ALA LEU PRO THR ILE PRO TYR HIS LYS SEQRES 2 G 306 LEU ALA ASP LEU ARG TYR LEU SER ARG GLY ALA SER GLY SEQRES 3 G 306 THR VAL SER SER ALA ARG HIS ALA ASP TRP ARG VAL GLN SEQRES 4 G 306 VAL ALA VAL LYS HIS LEU HIS ILE HIS THR PRO LEU LEU SEQRES 5 G 306 ASP SER GLU ARG LYS ASP VAL LEU ARG GLU ALA GLU ILE SEQRES 6 G 306 LEU HIS LYS ALA ARG PHE SER TYR ILE LEU PRO ILE LEU SEQRES 7 G 306 GLY ILE CYS ASN GLU PRO GLU PHE LEU GLY ILE VAL THR SEQRES 8 G 306 GLU TYR MET PRO ASN GLY SER LEU ASN GLU LEU LEU HIS SEQRES 9 G 306 ARG LYS THR GLU TYR PRO ASP VAL ALA TRP PRO LEU ARG SEQRES 10 G 306 PHE ARG ILE LEU HIS GLU ILE ALA LEU GLY VAL ASN TYR SEQRES 11 G 306 LEU HIS ASN MET THR PRO PRO LEU LEU HIS HIS ASP LEU SEQRES 12 G 306 LYS THR GLN ASN ILE LEU LEU ASP ASN GLU PHE HIS VAL SEQRES 13 G 306 LYS ILE ALA ASP PHE GLY LEU SER LYS TRP ARG MET MET SEQRES 14 G 306 SER LEU SER GLN SER ARG SER SER LYS SER ALA PRO GLU SEQRES 15 G 306 GLY GLY THR ILE ILE TYR MET PRO PRO GLU ASN TYR GLU SEQRES 16 G 306 PRO GLY GLN LYS SER ARG ALA SER ILE LYS HIS ASP ILE SEQRES 17 G 306 TYR SER TYR ALA VAL ILE THR TRP GLU VAL LEU SER ARG SEQRES 18 G 306 LYS GLN PRO PHE GLU ASP VAL THR ASN PRO LEU GLN ILE SEQRES 19 G 306 MET TYR SER VAL SER GLN GLY HIS ARG PRO VAL ILE ASN SEQRES 20 G 306 GLU GLU SER LEU PRO TYR ASP ILE PRO HIS ARG ALA ARG SEQRES 21 G 306 MET ILE SER LEU ILE GLU SER GLY TRP ALA GLN ASN PRO SEQRES 22 G 306 ASP GLU ARG PRO SER PHE LEU LYS CYS LEU ILE GLU LEU SEQRES 23 G 306 GLU PRO VAL LEU ARG THR PHE GLU GLU ILE THR PHE LEU SEQRES 24 G 306 GLU ALA VAL ILE GLN LEU LYS